SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis

SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis

Aim: To provide a pooled effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on cardiovascular outcomes in patients with heart failure with preserved ejection fraction (HFpEF: ≥50%) or/and mildly reduced EF (HFmrEF: 41–49%) regardless of baseline diabetes. Methods: We systemically searched...

Full description

Bibliographic Details
Main Authors: Mainak Banerjee, Rimesh Pal, Kirthana Nair, Satinath Mukhopadhyay
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Indian Heart Journal
Subjects:
SGLT2 inhibitors
Heart failure
T2DM
Dapagliflozin
Empagliflozin
Sotagliflozin
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483223000433

Internet

http://www.sciencedirect.com/science/article/pii/S0019483223000433

Similar Items